Nautilus Biotechnology (NAUT) goes public via SPAC, raises $345 million to commercialize proteome analysis

Nautilus Biotechnology, co-founded by Sujal Patel and Parag Mallick, is going public on Nasdaq as NAUT through a SPAC merger that raised $345 million to advance a new proteome analysis platform aimed at accelerating biomedical research and drug development. Institutional backers include Bezos Expeditions, Vulcan Capital and Madrona Venture Group, and the deal closes on the 25th anniversary of Patel’s arrival in Seattle.

SSujal Patel MMadrona NNautilus Biotechnology